Piscitelli Dominic — SEC insider filings

SEC reporting owner CIK 1695028. 24 insider filings on record with FilingPulse; latest filed 2026-10-21.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2021-02-02 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oric Pharmaceuticals, Inc. (ORIC)Chief Financial Officer241 leg · 60,000 sh · $321,62422 legs · 257,169 sh · $3,141,77146

Insider filings — Piscitelli Dominic

FiledFormIssuerReported transactionsSource
2026-10-214Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 14,000 @ $4.36 · Sale (S): 14,000 @ $13.53 · Option exercise (M): 14,000 (derivative) @ $0EDGAR
2026-09-294Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 13,400 @ $4.36 · Sale (S): 13,400 @ $13.53 · Option exercise (M): 13,400 (derivative) @ $0EDGAR
2026-09-254Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 600 @ $4.36 · Sale (S): 100 @ $13.50 · Sale (S): 500 @ $13.51 · Option exercise (M): 600 (derivative) @ $0EDGAR
2026-08-284Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 52,000 @ $4.36 · Option exercise (M): 25,000 @ $6 · Sale (S): 77,000 @ $13.69 · Option exercise (M): 52,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2026-02-264Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 52,000 @ $4.36 · Sale (S): 52,000 @ $13.51 · Option exercise (M): 52,000 (derivative) @ $0EDGAR
2026-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 206,500 (derivative) @ $0 · Grant/award (A): 34,500 (derivative) @ $0EDGAR
2025-12-174Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 29,333 @ $0 · Sale (S): 10,720 @ $9.06 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 11,333 (derivative) @ $0EDGAR
2025-10-084Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 11,000 @ $4.36 · Sale (S): 11,000 @ $14.52 · Option exercise (M): 11,000 (derivative) @ $0EDGAR
2025-07-024Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 20,000 @ $10.05EDGAR
2025-06-244Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 584 @ $10 · Sale (S): 450 @ $10.01 · Sale (S): 32,466 @ $10.50EDGAR
2025-06-134Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 300 @ $10EDGAR
2025-06-114Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 324 @ $10 · Sale (S): 1,276 @ $10 · Sale (S): 1,700 @ $10.01EDGAR
2025-06-094Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 2,600 @ $10.01 · Sale (S): 300 @ $10EDGAR
2025-01-034Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 202,500 (derivative) @ $0 · Grant/award (A): 34,000 (derivative) @ $0EDGAR
2024-12-174Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 24,042 @ $0 · Sale (S): 8,851 @ $8.28 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-01-034Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 180,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-12-194Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 14,042 @ $0 · Sale (S): 5,282 @ $8.58 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2023-02-174/AOric Pharmaceuticals, Inc. (ORIC)Sale (S): 2,227 @ $3.08EDGAR
2023-02-024Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 145,000 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2022-12-164Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 6,041 @ $0 · Sale (S): 2,089 @ $3.25 · Option exercise (M): 6,041 (derivative) @ $0EDGAR
2022-07-214Oric Pharmaceuticals, Inc. (ORIC)Disposition to issuer (D): 207,500 (derivative) · Disposition to issuer (D): 86,250 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 108,750 (derivative) · Grant/award (A): 207,500 (derivative) · Grant/award (A): 86,250 (derivative) · +2 moreEDGAR
2022-03-314Oric Pharmaceuticals, Inc. (ORIC)Purchase (P): 60,000 @ $5.36EDGAR
2022-02-024Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 108,750 (derivative) @ $0 · Grant/award (A): 18,125 (derivative) @ $0EDGAR
2021-02-024Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 90,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1695028 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs